» Articles » PMID: 32022249

P2X7 Receptor-targeted Regulation by Tetrahydroxystilbene Glucoside in Alcoholic Hepatosteatosis: A New Strategy Towards Macrophage-hepatocyte Crosstalk

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2020 Feb 6
PMID 32022249
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Regulating macrophage-hepatocyte crosstalk through P2X7 receptors has led to new pharmacological strategies to reverse alcoholic hepatosteatosis. We investigated how tetrahydroxystilbene glucoside (2354glu), isolated from Polygonum multiflorum, modulates macrophage-hepatocyte crosstalk during alcoholic hepatosteatosis.

Experimental Approach: A model of alcoholic hepatosteatosis was established by giving ethanol intragastrically to C57BL/6 mice. HepG2 cells were incubated in conditioned medium from LPS+ATP-activated THP-1 human macrophages with silenced or overexpressed P2X7 receptors. THP-1 macrophages or mouse peritoneal macrophages were pretreated with 2354glu for 1 hr prior to LPS+ATP stimulation. Western blots, RT-PCR and immunohistochemical analysis were used, along with over-expression and silencing of P2X7 receptors.

Key Results: Knockdown or overexpression of P2X7 receptors in THP-1 macrophages affected release of mature IL-1β and, subsequently, modulated lipid metabolism in HepG2 cells via the LKB-AMPK pathway. 2354glu ameliorated alcoholic hepatosteatosis in mice by regulating LKB1-AMPK-SREBP1 pathway and its target genes. Suppression of P2X7 receptor activation by 2354glu inhibited IL-1β release and reduced macrophage and neutrophil infiltration. In macrophages stimulated with LPS+ATP, expression of P2X7 receptors, caspase-1 and NF-κB, release of IL-1β, calcium influx and PI uptake were reduced by 2354glu. SIRT1-LKB1-AMPK-SREBP1 axis-mediated lipid accumulation in HepG2 cells was reduced when they were cultured with conditioned media from LPS+ATP-activated THP-1 macrophages pretreated with 2354glu.

Conclusion And Implications: Modulation of P2X7 receptors in macrophages regulated lipid accumulation in hepatocytes during alcoholic hepatosteatosis. 2354glu might be a promising candidate that targets P2X7 receptors in macrophages interacting with hepatocytes during alcoholic hepatosteatosis.

Citing Articles

Channel plan: control of adaptive immune responses by pannexins.

Santiago-Carvalho I, Ishikawa M, Borges da Silva H Trends Immunol. 2024; 45(11):892-902.

PMID: 39393945 PMC: 11560585. DOI: 10.1016/j.it.2024.09.009.


The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma.

Xie Q, Zeng Y, Zhang X, Yu F Cancer Immunol Immunother. 2024; 73(9):171.

PMID: 38954021 PMC: 11220057. DOI: 10.1007/s00262-024-03748-9.


Hypoxia-inducible factor 1 alpha (HIF-1α) stimulated and P2X7 receptor activated by COVID-19, as a potential therapeutic target and risk factor for epilepsy.

Zalpoor H, Akbari A, Nabi-Afjadi M, Forghaniesfidvajani R, Tavakol C, Barzegar Z Hum Cell. 2022; 35(5):1338-1345.

PMID: 35831562 PMC: 9281298. DOI: 10.1007/s13577-022-00747-9.


The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications.

Rotondo J, Mazziotta C, Lanzillotti C, Stefani C, Badiale G, Campione G Cancers (Basel). 2022; 14(5).

PMID: 35267424 PMC: 8909580. DOI: 10.3390/cancers14051116.


A Review of Pharmacology, Toxicity and Pharmacokinetics of 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-Glucoside.

Wang C, Dai S, Gong L, Fu K, Ma C, Liu Y Front Pharmacol. 2022; 12:791214.

PMID: 35069206 PMC: 8769241. DOI: 10.3389/fphar.2021.791214.


References
1.
Alexander S, Mathie A, Peters J, Veale E, Striessnig J, Kelly E . THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels. Br J Pharmacol. 2019; 176 Suppl 1:S142-S228. PMC: 6844578. DOI: 10.1111/bph.14749. View

2.
Curtis M, Alexander S, Cirino G, Docherty J, George C, Giembycz M . Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. Br J Pharmacol. 2018; 175(7):987-993. PMC: 5843711. DOI: 10.1111/bph.14153. View

3.
Shang Y, Li X, Jin M, Li Y, Wu Y, Jin Q . Leucodin attenuates inflammatory response in macrophages and lipid accumulation in steatotic hepatocytes via P2x7 receptor pathway: A potential role in alcoholic liver disease. Biomed Pharmacother. 2018; 107:374-381. DOI: 10.1016/j.biopha.2018.08.009. View

4.
Singal A, Bataller R, Ahn J, Kamath P, Shah V . ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol. 2018; 113(2):175-194. PMC: 6524956. DOI: 10.1038/ajg.2017.469. View

5.
Zhang Y, Jiang M, Cui B, Hua Jin C, Wu Y, Shang Y . P2X7 receptor-targeted regulation by tetrahydroxystilbene glucoside in alcoholic hepatosteatosis: A new strategy towards macrophage-hepatocyte crosstalk. Br J Pharmacol. 2020; 177(12):2793-2811. PMC: 7236069. DOI: 10.1111/bph.15007. View